Skip to main content
. 2022 Feb 16;13:821689. doi: 10.3389/fendo.2022.821689

Figure 2.

Figure 2

Cross-lagged path analysis pattern diagram. SUA, serum uric acid; HSI, hepatic steatosis index *: β1, baseline hyperuricemia to subsequent MAFLD; β2, baseline MAFLD to subsequent hyperuricemia; MAFLD, metabolic dysfunction-associated fatty liver disease.